Brand and Other Names:Lamisil AT topical
- Classes: Antifungals, Topical
Dosing & Uses
Dosage Forms & Strengths
Apply to affected area BID until significant clinical improvement (no more than 4 weeks)
Tinea Corporis & Cruris
Apply qDay x1 week (no more than 4 weeks)
Not FDA approved for peds
Not for oral, intravaginal, ophthalmic use
Pregnancy & Lactation
Pregnancy Category: B
Lactation: not safe for nursing infants
A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA:Information not available.
Mechanism of Action
Inhibits squalene epoxidase, reducing cell membrane ergosterol synthesis